REFERENCES
1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-11.
2. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, et al; ESC Scientific Document Group. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017;38:2739-91.
3. Iung B. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231-43.
4. Antoine C, Mantovani F, Benfari G, Mankad SV, Maalouf JF, et al. Pathophysiology of degenerative mitral regurgitation: new 3-Dimensional imaging insights. Circ Cardiovasc Imaging 2018;11:e005971.
5. Adams DH, Rosenhek R, Falk V. Degenerative mitral valve regurgitation: best practice revolution. Eur Heart J 2010;31:1958-66.
6. Freed LA, Levy D, Levine RA, Larson MG, Evans JC, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 1999;341:1-7.
7. Freed LA, Benjamin EJ, Levy D, Larson MG, Evans JC, et al. Mitral valve prolapse in the general population. J Am Coll Cardiol 2002;40:1298-304.
8. Kolibash AJ. Progression of mitral regurgitation in patients with mitral valve prolapse. Herz 1988;13:309-17.
9. Ma JI, Igata S, Strachan M, Nishimura M, Wong DJ, et al. Predictive factors for progression of mitral regurgitation in asymptomatic patients with mitral valve prolapse. Am J Cardiol 2019;123:1309-13.
10. Mirabel M, Iung B, Baron G, Messika-Zeitoun D, Détaint D, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 2007;28:1358-65.
11. De Bonis M, Lapenna E, Alfieri O. Edge-to-edge Alfieri technique for mitral valve repair: which indications? Curr Opin Cardiol 2013;28:152-7.
12. O’Gara P, Sugeng L, Lang R, Sarano M, Hung J, et al. The role of imaging in chronic degenerative mitral regurgitation. JACC Cardiovasc Imaging 2008;1:221-37.
13. Feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, et al; EVEREST Investigators. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 2009;54:686-94.
14. Li CH, Arzamendi D, Carreras F. Role of imaging techniques in percutaneous treatment of mitral regurgitation. Rev Esp Cardiol (Engl Ed) 2016;69:421-36.
15. Eggebrecht H, Schelle S, Puls M, Plicht B, von Bardeleben RS, et al. Risk and outcomes of complications during and after MitraClip implantation: Experience in 828 patients from the German TRAnscatheter mitral valve interventions (TRAMI) registry. Catheter Cardiovasc Interv 2015;86:728-35.
16. Praz F, Spargias K, Chrissoheris M, Büllesfeld L, Nickenig G, et al. Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study. Lancet 2017;390:773-80.
17. Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, et al; EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011;364:1395-406.
18. Feldman T, Kar S, Elmariah S, Smart SC, Trento A, et al; EVEREST II investigators. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol 2015;66:2844-54.
19. Buzzatti N, Van Hemelrijck M, Denti P, Ruggeri S, Schiavi D, et al. Transcatheter or surgical repair for degenerative mitral regurgitation in elderly patients: a propensity-weighted analysis. J Thorac Cardiovasc Surg 2019;158:86-94.e1.
20. Lim DS, Reynolds MR, Feldman T, Kar S, Herrmann HC, et al. Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair. J Am Coll Cardiol 2014;64:182-92.
21. Jorbenadze R, Schreieck J, Barthel C, Seizer P, Schlensak C, et al. Percutaneous edge-to-edge mitral valve repair using the new MitraClip XTR System. JACC Cardiovasc Interv 2018;11:e93-5.
22. Weinmann K, Markovic S, Rottbauer W, Keßler M. First experience with the MitraClip XTR device for extensive mitral valve prolapse (Barlow’s disease). EuroIntervention 2018;14:e1276-7.
23. Lim DS, Kar S, Spargias K, Kipperman RM, O’Neill WW, et al. Transcatheter valve repair for patients with mitral regurgitation: 30-day results of the CLASP study. JACC Cardiovasc Interv 2019;12:1369-78.
24. Mazimba S, Lim SD, Kipperman R, Spargias K, Kar S, et al. Six-month outcomes from the multicenter, prospective study with the novel PASCAL transcatheter valve repair system for patients with mitral regurgitation in the CLASP study. J Card Fail 2019;25:S6.
25. Kar S, Ng M, Lim S, Walters D, Webb J, et al. TCT-91 1-year outcomes from the multicenter, prospective study with the novel PASCAL transcatheter valve repair system for patients with mitral regurgitation in the CLASP study. J Am Coll Cardiol 2019;74:B91.
26. Glower DD, Kar S, Trento A, Lim DS, Bajwa T, et al. Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study. J Am Coll Cardiol 2014;64:172-81.
27. Maisano F, Franzen O, Baldus S, Schäfer U, Hausleiter J, et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol 2013;62:1052-61.
28. Nickenig G, Estevez-Loureiro R, Franzen O, Tamburino C, Vanderheyden M, et al; Transcatheter Valve Treatment Sentinel Registry Investigators of the EURObservational Research Programme of the European Society of Cardiology. Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry. J Am Coll Cardiol 2014;64:875-84.
29. Puls M, Lubos E, Boekstegers P, von Bardeleben RS, Ouarrak T, et al. One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry. Eur Heart J 2016;37:703-12.
30. Capodanno D, Adamo M, Barbanti M, Giannini C, Laudisa ML, et al; GRASP-IT Investigators. Predictors of clinical outcomes after edge-to-edge percutaneous mitral valve repair. Am Heart J 2015;170:187-95.
31. Sorajja P, Vemulapalli S, Feldman T, Mack M, Holmes DR Jr, et al. Outcomes with transcatheter mitral valve repair in the United States: an STS/ACC TVT registry report. J Am Coll Cardiol 2017;70:2315-27.
